Rigel Pharmaceuticals
The Senior Regional Marketer drives the execution of Rigel's oncology portfolio strategy, focusing on the launch and commercialization of VEPPANU while providing lifecycle marketing support for other oncology assets. This role translates national strategy into regional execution through customer engagement, KOL partnerships, and regional marketing initiatives to optimize launch performance and inform commercial strategy. The position requires strong oncology commercial expertise and cross-functional collaboration across a matrix organization.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
1996
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. The company markets approved products including TAVALISSE, REZLIDHIA, and Gavreto, and maintains a pipeline of clinical programs including IRAK1/4 and RIPK1 inhibitors. Rigel is publicly traded under the ticker RIGL and is headquartered in South San Francisco, California.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rigel Pharmaceuticals.
Associate Director, Regional Marketer
ADC Therapeutics
Associate Director, Regional Marketer
ADC Therapeutics
Global Marketing Director, Oncology
GSK plc
Associate Director, Regional Marketer
ADC Therapeutics
Vice President of Marketing and Sales
Tango Therapeutics
Director, US Oncology Marketing, Breast Cancer Strategy Lead
MSD